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A B S T R A C T
Adjunctive percutaneous coronary intervention (PCI) performed between 2 and 24 
hours after thrombolysis administered to a patient with an ST elevation myocardial 
infarction (STEMI) appears beneficial and safe. The rationale for routinely following 
fibrinolysis with PCI is that many patients have a persistent reduction in flow in the 
infarct-related artery; although fibrinolysis restores patency (TIMI grade 2 or 3) in 
80% of infarct-related arteries, normalization of blood flow (TIMI grade 3) is seen in 
only 50 to 60% of arteries. Adjunctive PCI has been directly compared to a strategy of 
fibrinolysis and standard care (either PCI for a clinical indication or routine late PCI) 
in the TRANSFER AMI, GRACIA-1, NORDISTEMI, CARESS-in-AMI, and SI-
AM III trials, and found to have better outcomes. Based on these results, the 2010 Eu-
ropean Society of Cardiology (ESC) guidelines recommend routine urgent PCI after 
successful fibrinolysis within 24 hours (class I recommendation, level of evidence A).
A D J U N C T I V E  P C I  I N  A C U T E  M Y O C A R D I A L  I N F A R C T I O N
In contrast to the adverse effects seen with facilitated percutaneous coronary in-
tervention (PCI) in the ASSENT-4 study, when catheterization was performed usually 
within 2 hours of fibrinolysis in patients with acute myocardial infarction, adjunctive 
PCI performed between 2 and 24 hours appears beneficial and safe. The rationale for 
following fibrinolysis with PCI is that many patients have a persistent reduction in flow 
in the infarct-related artery. Although fibrinolysis restores patency (TIMI grade 2 or 3) 
in 80% of infarct-related arteries, normalization of blood flow (TIMI grade 3) is seen 
in only 50 to 60% of arteries. As mentioned above, the clinical benefits of fibrinolytic 
therapy are seen only with the restoration of normal flow.1,2
Evidence suggesting that the routine use of PCI after fibrinolysis is equivalent to 
PCI comes from the GRACIA-2 trial and the FAST-MI registry:
 - In the GRACIA-2 non-inferiority trial, patients were randomly assigned to full 
dose tenecteplase followed by stenting within 3 to 12 (mean of 4.6) hours of rand-
omization or to primary stenting within 3 hours of randomization.3 Compared to 
primary PCI alone, the early routine post-fibrinolysis PCI group had a significantly 
higher frequency of complete epicardial and myocardial reperfusion (21% versus 
6%), which was defined as TIMI 3 epicardial flow, TIMI 3 myocardial perfusion, 
and resolution of the initial sum of ST-segment elevation 70%. Both groups were 
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ABBREVIATIONS
ACC = American College of Cardiology
AHA = American heart Association
ASSENT = ASsessment of the Safety and 
Efficacy of a New Treatment Strategy for 
Acute Myocardial Infarction (study)
CABG = coronary artery bypass grafting
CARESS-in-AMI = Combined Abciximab 
RE-teplase Stent Study in Acute 
Myocardial Infarction (study)
CK = creatine kinase
ESC = European Society of Cardiology
FAST-MI = French Registry on Acute ST-
Elevation Myocardial Infarction (study)
GRACIA = Groupo de Análisis de 
Cardiopatía Isquémica Aguda (study)
NORDISTEMI = NORwegian study on 
DIstrict treatment of ST-elevation 
myocardial infarction (study)
PCI = percutaneous coronary intervention
SCAI = Society for Cardiovascular 
Angiography and Interventions
SIAM III = Streptokinase in Acute 
Myocardial Infarction (study)
STEMI = ST elevation myocardial infarction
TIMI = thrombolysis in myocardial 
infarction
TRANSFER AMI = Trial of Routine 
Angioplasty and Stenting after 
Fibrinolysis to Enhance Reperfusion in 
Acute Myocardial Infarction (study)
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similar in terms of the extent of left ventricular myocardial 
damage (area under the CK and troponin curves and left 
ventricular ejection fraction at 6 weeks) and in terms of 
the 6-month composite incidence of death, reinfarction, 
stroke, or revascularization.
 - In the FAST-MI registry of 1714 real-world ST-elevation 
myocardial infarction (STEMI) patients treated with 
primary PCI, fibrinolysis followed by PCI, or no reperfu-
sion, there was no significant difference with regard to 
in-hospital (4.3% versus 5%) or one year mortality (6% 
versus 8%) between the two reperfusion groups.4
Adjunctive PCI has been directly compared to a strategy of 
fibrinolysis and standard care (either PCI for a clinical indica-
tion or routine late PCI) in the TRANSFER AMI, GRACIA-1, 
NORDISTEMI, CARESS-in-AMI, and SIAM III trials.5-9 
Although each trial had a different study design, and therefore 
addressed slightly different patient populations, a strategy of 
adjunctive PCI (between 2 and 6 hours after fibrinolysis) had 
better outcomes than a strategy of standard care. The first 
three of these trials represent the best available evidence.
TRANSFER AMI trial — In the TRANSFER AMI trial, 
1059 high-risk STEMI patients, who presented to a non-PCI 
hospital and were treated with fibrinolytic therapy (tenect-
eplase) within 2 hours of the onset of chest pain, were randomly 
assigned to either urgent transfer for cardiac catheterization 
(PCI within 6 hours) or to standard care.5 High risk was defined 
as ST-segment elevation 2 mm in two anterior leads or ST-
segment elevation 1 mm in two inferior leads plus at least 
one of the following: systolic blood pressure of <100 mmHg, 
heart rate >100 beats/min, Killip class II or III, ST-segment 
depression 2 mm in the anterior leads, or ST-segment eleva-
tion 1 mm in right-sided lead V4 (V4R). Standard care was 
defined as transfer for rescue and/or urgent PCI or for routine 
catheterization after 24 hours.
The mean time to catheterization after fibrinolysis was 3 
hours in the urgent transfer group and 33 hours in the stand-
ard care group. At 30 days, the primary composite end-point 
(death, reinfarction, heart failure, severe recurrent ischemia or 
shock) occurred significantly less often in the urgent transfer 
group (11% versus 17.2%; odds ratio-OR 0.64, 95% confidence 
intervals-CI 0.47-0.87). Most of the benefit was attributable to 
a reduction in reinfarction or recurrent ischemia. The bleeding 
rates were similar in the two groups.
NORDISTEMI trial — In the NORDISTEMI trial, 266 
low to high risk patients with STEMI, with expected transfer 
delays of more than 90 minutes, were treated with fibrino-
lytic therapy and then randomly assigned to a strategy of 
either immediate transfer for angiography/possible PCI or 
ischemia-guided treatment in local hospitals.9 In the invasive 
and conservative groups, PCI was performed in 89% and 71% 
and at a median time of 163 minutes and 3 days respectively.
The primary end point of death, reinfarction, stroke, or 
new ischemia at one year did not differ between the invasive 
and conservative groups (20.9% versus 27.3%, hazard ratio 
[HR] 0.72; 95% CI 0.44-1.18 respectively). However, the sec-
ondary end point of death, reinfarction, or stroke at one year 
was significantly lower in the invasive arm (6% versus 15.9%, 
HR 0.36; 95% CI 0.16-0.81).
GRACIA-1 trial — In the GRACIA-1 trial, 500 patients 
with an acute STEMI were treated with full dose fibrinolytic 
therapy and then randomly assigned to either angiography 
and PCI if indicated or ischemia-driven cardiac catheteriza-
tion in less than 24 hours (mean 17 hours) followed by PCI 
with stenting or coronary artery bypass grafting (CABG), if 
appropriate.6 The primary end-point was death, myocardial 
infarction, or ischemia-driven revascularization.
At one year, interventional therapy was associated with a 
significant reduction in the incidence of the primary end-point 
(23% versus 51%) and a trend toward a reduction in the in-
cidence of death or myocardial infarction (17% versus 29%). 
Interventional therapy was also associated with significantly 
shorter hospitalization (7 versus 11 days) and no increase in 
bleeding.
A D J U N C T I V E  O R  E A R L Y  E L E C T I V E  P C I 
—  M A J O R  S O C I E T Y  G U I D E L I N E S
Major society guidelines have come to varying conclusions 
about the value of angiography followed, if the anatomy is 
suitable, by adjunctive or early elective PCI:
The 2005 ESC guidelines concluded that the evidence 
supported routine coronary angiography after successful 
fibrinolysis. 10
The 2007 ACC/AHA focused update on STEMI and the 
2007 ACC/AHA/SCAI focused update for PCI came to the 
following conclusions:
 - Coronary angiography and, if appropriate, PCI after 
fibrinolysis was recommended in patients with recurrent 
myocardial infarction, moderate to severe spontaneous or 
provocable ischemia during recovery, or cardiogenic shock 
or hemodynamic instability.11-13
 - PCI was thought reasonable in patients with a left ventricu-
lar ejection fraction 40%, serious ventricular arrhythmias, 
or clinical heart failure during the acute episode even 
though subsequent evaluation shows a left ventricular 
ejection fraction >40%.11-13
 - PCI of a hemodynamically significant stenosis in a pat-
ent infarct artery greater than 24 hours after STEMI was 
thought reasonable.
 - PCI of a totally occluded artery greater than 24 hours after 
STEMI in patients who had one or two vessel disease, 
were hemodynamically and electrically stable, and had 
no evidence of severe ischemia was not recommended.
The 2009 ACC/AHA focused update on STEMI gave a 
weak recommendation for the transfer of high risk patients who 
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received fibrinolytic therapy from hospitals not capable of PCI 
as part of a pharmacoinvasive strategy.12 They also considered it 
reasonable to use the same approach for low-risk patients.
According to the 2010 ESC guidelines, routine urgent 
PCI is indicated after successful fibrinolysis (resolved chest 
pain/discomfort and ST-segment elevation) within 24 hours 
(class I recommendation, level of evidence A). In the case of 
successful fibrinolysis, patients are referred within 24 hours 
for angiography and revascularization as required.14,15
We generally agree with the ESC guidelines, which sup-
port routine coronary angiography after fibrinolysis in most 
patients, even in the absence of ischemia at rest or after stress, 
arrhythmias, left ventricular dysfunction, or heart failure.10 
Patients with important co-morbidities or a strong preference 
to not undergo coronary angiography may be candidates for 
medical therapy.
S U M M A R Y  A N D  R E C O M M E N D A T I O N S 
In stable STEMI patients who have received fibrinolysis, 
the following recommendations exist:
 - Due to the possibility of reocclusion after apparently suc-
cessful fibrinolysis, immediate transfer of all patients who 
have received fibrinolytic therapy (including those who 
appear to be at low risk), either in a non-PCI hospital or in 
an ambulance, to a PCI capable hospital is recommended.
 - It is NOT recommended to perform planned PCI within 
the first two hours. This is known as facilitated PCI, and 
is associated with worse outcomes.
 - For patients with high-risk features, including but not 
limited to anterior myocardial infarction, Killip class 2, 
inferior infarction with evidence of right ventricular in-
volvement, systolic blood pressure of <100 mmHg, heart 
rate >100 beats/min, immediate (any time after 2 hours) 
diagnostic angiography and PCI if needed, as opposed to 
a strategy of PCI only for an indication such as clinical 
instability or inducible ischemia is recommended.
 - For patients not at high risk, routine coronary angiog-
raphy and PCI if indicated as opposed to a strategy of 
coronary angiography (with PCI if indicated) only for an 
indication such as clinical instability or inducible ischemia 
is recommended. Although the optimal timing of routine 
angiography and possible PCI for such patients has not 
been determined, it should be performed within 6 to 24 
hours. However, catheterization for indication only is a 
reasonable strategy for patients at low risk who have a 
preference to not undergo routine coronary angiography.
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